4th Quarter - Termination

MEHLMAN CONSULTING, INC. for MARATHON PHARMACEUTICALS, LLC

Firm
Client
Income
$10,000
Expenses
—
Terminated
Dec 31, 2015

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 14, 2016 $10,000 Replaced
4th Quarter - Termination (this page) Mar 9, 2016 $10,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pediatric rare disease voucher program. H.R. 2029, The Consolidated Appropriations Act.

LobbyistCovered position, as disclosed
SOHINI GUPTA —
MICHAEL ROBINSON —
DEAN ROSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2029 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.